Latest DDSC news
Samsung Bioepis and Teva expand strategic partnership to advance up to six potential biosimilar candidates
Samsung Bioepis and Teva Pharmaceutical have entered into a global licence, development and commercialisation agreement for up to six...
Bespak expands next-generation nasal offering with launch of NasaDose ultra soft unit dose spray
Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO) focused exclusively on inhaled and nasal drug delivery, will...
Dr Oregonin completes US FDA registration for Oltis Dental-X, unveiling oral-care innovation rooted in trans-Pacific alder research
Dr Oregonin Inc has completed US Food and Drug Administration (FDA) registration for OLTIS DENTAL-X, paving the way for...
Esteve CDMO expands US capacity with additional $17.5 million investment in Morton Grove
Esteve CDMO, a global pure-play CDMO specialising in the development and manufacture of small-molecule APIs and pharmaceutical intermediates, is...
Hovione to commission world’s first ConsiGma CDC flex, bringing next-generation continuous tableting to the US
Hovione, a globally integrated pharmaceutical contract development and manufacturing organisation (CDMO), will commission the world's first ConsiGma CDC flex...
West to highlight industry leadership in packaging and containment at CPHI worldwide
West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, will highlight its leadership and expertise...
Yourgene Health Insight DPYD assay achieves IVDR accreditation
Yourgene Health, an international molecular diagnostics company with a broad portfolio of integrated technologies and services, has announced the...
AstraZeneca completes global license agreement for oral EGFR inhibitor Zegfrovy for lung cancer
AstraZeneca has started an exclusive licencing agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), an oral irreversible epidermal growth factor receptor (EGFR)...
Northway Biotech opens (first in Baltics) EUR €61 million cell therapy and personalised medicine CDMO in Vilnius, Lithuania
Building on more than 22 years of CDMO experience across biologics and advanced therapies, Northway Biotech is significantly expanding...
InnovHeart announces first US Saturn transseptal TMVR system implant, reaching 15 patients globally
InnovHeart, a medical device company developing the Saturn Transseptal Transcatheter Mitral Valve Replacement (TMVR) System, today announces the successful...
Cipla announces exclusive partnership with Qilu Pharmaceutical for the licensing and supply of biosimilar to Keytruda (Pembrolizumab) in the US
Invagen Pharmaceuticals has entered into a strategic partnership with Qilu Pharmaceutical Co, for the exclusive licensing and supply of QL2107, a...
ENA Respiratory awarded Biointelect Venturer funding to support new study in asthma patients of INNA-051 nasal spray designed to protect against symptomatic viral respiratory infections
ENA Respiratory, a clinical-stage pharmaceutical company developing host defence enhancers for the prevention of complications associated with respiratory viral infections in at-risk...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular